Adam S. Grossman is CEO & President at ADMA BIOLOGICS, INC. (ADMA). They have made 35 open-market trades across 1 company since 2013, most recently 2026-03-16.
CIK 0001542517
29 open-market purchases totalling $5.0M since 2013, against 6 sales. Across 29 scored buys the stock is down 8.8% at ninety days, and 9.1 points behind the S&P over the same stretch.
29 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ADMA | 2,112,777 | $22.6M |
| PrivateUnlisted | 438,919 | — |
| Total | $22.6M |
Shares reported on the most recent Form 4, priced at the 2026-03-17 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 10% | 10% | 10% |
| Avg Move | -14.3% | -4.8% | -8.8% |
| Alpha | -10.0% | -4.2% | -9.1% |
| Scored | 29 | 29 | 29 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADMA | SELL · 10b5-1 | 2026-03-16 | 2026-03-17 | $15.16 | $318K | -42.0% | -32.6% | -46.7% |
| ADMA | SELL | 2026-02-17 | 2026-02-17 | $16.08 | $338K | -2.3% | -5.7% | -47.3% |
| ADMA | SELL · 10b5-1 | 2025-12-15 | 2025-12-16 | $19.79 | $416K | +0.4% | -8.0% | -16.8% |
| ADMA | SELL · 10b5-1 | 2025-11-19 | 2025-11-21 | $16.00 | $336K | +16.7% | +15.4% | -5.3% |
| ADMA | SELL · 10b5-1 | 2025-10-24 | 2025-10-24 | $16.00 | $336K | +0.5% | +19.7% | +13.7% |
| ADMA | SELL · 10b5-1 | 2025-09-15 | 2025-09-16 | $16.13 | $581K | -0.5% | -7.2% | +25.7% |
| ADMA | SELL · 10b5-1 | 2025-08-15 | 2025-08-15 | $16.88 | $608K | +1.0% | -10.4% | -8.1% |
| ADMA | SELL · 10b5-1 | 2025-07-15 | 2025-07-16 | $18.66 | $392K | +2.0% | -3.7% | -15.3% |
| ADMA | SELL · 10b5-1 | 2025-06-16 | 2025-06-18 | $20.81 | $562K | -1.3% | -7.7% | -13.4% |
| ADMA | SELL · 10b5-1 | 2025-05-15 | 2025-05-16 | $19.45 | $408K | +0.6% | +3.8% | -13.6% |
| ADMA | SELL · 10b5-1 | 2025-04-15 | 2025-04-16 | $21.46 | $451K | +13.4% | -7.4% | -15.5% |
| ADMA | SELL · 10b5-1 | 2025-03-19 | 2025-03-21 | $18.92 | $511K | +1.3% | -1.7% | -11.2% |
| ADMA | SELL | 2024-11-22 | 2024-11-22 | $21.10 | $2.1M | -9.9% | -17.3% | -25.0% |
| ADMA | SELL | 2024-08-26 | 2024-08-27 | $17.44 | $21.8M | +6.7% | +12.9% | +24.7% |
| ADMA | SELL | 2024-06-14 | 2024-06-14 | $10.72 | $1.1M | +3.7% | +26.8% | +67.1% |
| ADMA | SELL | 2023-08-18 | 2023-08-18 | $4.15 | $2.1M | -10.3% | -10.8% | -6.6% |
| ADMA | SELL | 2023-08-15 | 2023-08-17 | $4.54 | $4.6M | -10.6% | -13.9% | -10.2% |
| ADMA | BUY | 2022-12-09 | 2022-12-09 | $2.86 | $86K | +2.2% | -2.8% | -9.1% |
| ADMA | BUY | 2021-10-25 | 2021-10-26 | $1.00 | $350K | -2.9% | +3.6% | -0.7% |
| ADMA | BUY | 2020-09-08 | 2020-09-10 | $2.24 | $9K | -3.9% | +4.3% | -4.3% |
| ADMA | BUY | 2020-08-10 | 2020-08-12 | $3.04 | $18K | -1.0% | -22.8% | -37.2% |
| ADMA | BUY | 2020-02-11 | 2020-02-11 | $3.50 | $600K | -7.9% | -42.4% | -29.7% |
| ADMA | BUY | 2019-05-17 | 2019-05-21 | $4.00 | $120K | -5.6% | -18.0% | -7.9% |
| ADMA | BUY | 2018-06-08 | 2018-06-11 | $4.78 | $700K | +3.6% | -6.2% | +38.2% |
| ADMA | BUY | 2017-11-09 | 2017-11-13 | $2.15 | $1.0M | +12.7% | -10.6% | +35.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.